Search by Drug Name or NDC
NDC 69315-0904-05 Lorazepam 0.5 mg/1 Details
Lorazepam 0.5 mg/1
Lorazepam is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Leading Pharma, LLC. The primary component is LORAZEPAM.
MedlinePlus Drug Summary
Lorazepam is used to relieve anxiety. Lorazepam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow for relaxation.
Related Packages: 69315-0904-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Lorazepam
Product Information
| NDC | 69315-0904 |
|---|---|
| Product ID | 69315-904_40249bb6-0d25-4b2f-aa4b-85c15af6bf8b |
| Associated GPIs | 57100060000305 |
| GCN Sequence Number | 003757 |
| GCN Sequence Number Description | lorazepam TABLET 0.5 MG ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 14160 |
| HICL Sequence Number | 004846 |
| HICL Sequence Number Description | LORAZEPAM |
| Brand/Generic | Generic |
| Proprietary Name | Lorazepam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lorazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | LORAZEPAM |
| Labeler Name | Leading Pharma, LLC |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA078203 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69315-0904-05 (69315090405)
| NDC Package Code | 69315-904-05 |
|---|---|
| Billing NDC | 69315090405 |
| Package | 500 TABLET in 1 BOTTLE (69315-904-05) |
| Marketing Start Date | 2023-05-16 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.04635 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | LORAZEPAM 0.5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis